Somatropin in short bowel syndrome: opening the door to trophic factor use

Author： DiBaise John K  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.1, 2006-01, pp. : 55-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic implications of growth hormone use in patients with short bowel syndrome

By Migliaccio-Walle Kristen   Caro J. Jaime   Möller Jörgen  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2055-2063

Informa Healthcare

Access to resources Recommend Favorite

Opportunities for Opening the Door to Transdiagnostic Approaches

By  

ALCOHOLISM (ELECTRONIC), Vol. 39, Iss. 4, 2015-04 ,pp. : 592-592

John Wiley & Sons Inc

Access to resources Recommend Favorite

Key issues in addressing the clinical and humanistic burden of short bowel syndrome in the US

By Hofstetter Steven   Stern Lee   Willet Jacob  

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 495-504

Informa Healthcare

Access to resources Recommend Favorite

Short bowel syndrome in infants: the critical role of luminal nutrients in a management program

By Roy Claude C.   Groleau Véronique   Bouthillier Lise   Pineault Marjolain   Thibault Maxime   Marchand Valérie  

Applied Physiology, Nutrition, and Metabolism, Vol. 39, Iss. 7, 2014-01 ,pp. : 745-753

NRC Research Press

Access to resources Recommend Favorite

Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS)

By Ekesbo Rickard   Nilsson Peter   Sjolund Kristina  

Scandinavian Journal of Primary Health Care, Vol. 26, Iss. 2, 2008-01 ,pp. : 106-110

Informa Healthcare

Access to resources Recommend Favorite